BCL2 and leukemia: The constitutive activation of B-cell receptor (BCR) signaling in the lymph nodes3, together with the overexpression of the Bcl-2 family anti-apoptotic proteins4 represent two hallmarks of CLL, that drive the leukemia cell proliferation and sustain their survival.